BSX vs FLYE · P/E 20, rev $16.75B vs rev $25.4M
Boston Scientific Corp (BSX) versus Fly-E Group, Inc. Common Stock (FLYE) — a side-by-side from cached financials, not a winner call.
Boston Scientific Corp (BSX) is a medical devices company listed on US.
Fly-E Group, Inc. Common Stock (FLYE) is a auto manufacturers company listed on NASDAQ.
Latest reported BSX revenue for 2024-12-31 was $16.75B. Net income was $1.85B. Revenue was up 17.6% from 2023-12-31 to 2024-12-31. BSX currently screens at market cap $71.81B and trailing P/E 20.2.
Latest reported FLYE revenue for 2025-03-31 was $25.4M. Net income was -$5.3M. Revenue was down 21.0% from 2024-03-31 to 2025-03-31. FLYE currently screens at market cap $3.8M.
BSX currently screens at market cap $71.81B and trailing P/E 20.2. FLYE currently screens at market cap $3.8M.
Not investment advice. Open the BSX and FLYE stock pages for the full models.
Not investment advice.